NgR3 Activators denote a range of compounds that can enhance the functionality of NgR3, a protein involved in various cellular processes including neurite outgrowth and calcium-mediated signaling. These compounds primarily exert their influence by manipulating various biological processes and pathways closely associated with the functional role of NgR3. For instance, FTY720 is a sphingosine 1-phosphate (S1P) receptor modulator. Activation of S1P receptors can lead to changes in cytoskeletal organization and neurite outgrowth, processes in which NgR3 is directly involved. Thus, by activating S1P receptors, FTY720 can enhance the functional activity of NgR3.
Other notable examples include U73122, a phospholipase C (PLC) inhibitor, and Thapsigargin, a SERCA pump inhibitor. Both these compounds influence intracellular calcium levels, which in turn can affect the functional activity of NgR3, given its involvement in calcium-mediated signaling pathways. Similarly, compounds such as PP2, an Src family kinase inhibitor, and MK-2206, an AKT inhibitor, canenhance the functional activity of NgR3 by inhibiting the respective kinases, which are known to regulate NgR3 through phosphorylation. Compounds such as Trichostatin A, a histone deacetylase (HDAC) inhibitor, LY294002 and Wortmannin, both PI3K inhibitors, along with BAY 11-7082, an IκB kinase (IKK) inhibitor, also contribute to the enhancement of NgR3 functionality. They do this by inhibiting the respective enzymes or kinases that regulate NgR3 through processes such as deacetylation or phosphorylation. On the other hand, compounds like BAPTA-AM, a cell-permeable calcium chelator, and Dantrolene, a ryanodine receptor antagonist, alter intracellular calcium levels, which subsequently enhances NgR3 functional activity considering its involvement in calcium-dependent signaling pathways. Lastly, KN-93, a Ca2+/calmodulin-dependent protein kinase (CamK) II inhibitor, can also enhance NgR3 activity by impeding the phosphorylation process of CamKII, a known regulator of NgR3.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine 1-phosphate (S1P) receptor modulator. Activation of S1P receptors can lead to changes in cytoskeletal organization and neurite outgrowth, processes in which NgR3 is directly involved. Thus, by activating S1P receptors, FTY720 can enhance the functional activity of NgR3. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src family kinases can phosphorylate and regulate NgR3, thus PP2 by inhibiting these kinases can enhance the functional activity of NgR3. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an AKT inhibitor. AKT can regulate NgR3 through phosphorylation, thus by inhibiting AKT, MK-2206 can enhance the functional activity of NgR3. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. HDACs can regulate NgR3 through deacetylation, hence by inhibiting HDACs, Trichostatin A can enhance the functional activity of NgR3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K can regulate NgR3 through phosphorylation, thus by inhibiting PI3K, LY294002 can enhance the functional activity of NgR3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that increases intracellular calcium levels. Since NgR3 is involved in calcium-mediated signaling pathways, changes in intracellular calcium levels can enhance NgR3 functional activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator. By chelating intracellular calcium, BAPTA-AM can alter calcium-mediated signaling pathways in which NgR3 is involved, enhancing its functional activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a Ca2+/calmodulin-dependent protein kinase (CamK) II inhibitor. CamKII can regulate NgR3 through phosphorylation, so by inhibiting CamKII, KN-93 can enhance the functional activity of NgR3. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene is a ryanodine receptor antagonist which can alter intracellular calcium levels. Since NgR3 is involved in calcium-mediated signaling pathways, changes in intracellular calcium levels can enhance NgR3 functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor. PI3K can regulate NgR3 through phosphorylation, thus by inhibiting PI3K, Wortmannin can enhance the functional activity of NgR3. | ||||||